Assessment of adverse events of tasimelteon: a real-world pharmacovigilance study based on FAERS
This study revealed the characteristics of tasimelteon-associated adverse drug reactions, improved understanding of drug safety, and provided valuable signals for optimizing drug use regimens. Additional large-scale prospective studies remain necessary in the future.
Authors
- Jingya Yang (ORCID: https://orcid.org/0000-0002-7419-5133)
- Hong-Yun Wu (ORCID: https://orcid.org/0009-0007-0810-3951)
- Teng Zuo
- Shengzhu Sun
- Wei Peng (ORCID: https://orcid.org/0009-0000-6038-0349)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1080/14740338.2025.2464068
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31